发明申请
- 专利标题： Enteroendocrine Manipulation for Metabolic Effect
- 专利标题（中）： 肠内分泌操作代谢作用
-
申请号： US13104282申请日： 2011-05-10
-
公开(公告)号： US20110295151A1公开(公告)日： 2011-12-01
- 发明人: Gregory J. Bakos , Edward G. Chekan , Denzel Z. Herrera-Davis , Jason L. Harris , Gary L. Long , Rudolph H. Nobis , Mark S. Ortiz , Mark D. Overmyer , David N. Plescia , Randy J. Seeley , William B. Weisenburgh, II , Tamara S. Vetro Widenhouse , Mark S. Zeiner , Andrew M. Zwolinski
- 申请人： Gregory J. Bakos , Edward G. Chekan , Denzel Z. Herrera-Davis , Jason L. Harris , Gary L. Long , Rudolph H. Nobis , Mark S. Ortiz , Mark D. Overmyer , David N. Plescia , Randy J. Seeley , William B. Weisenburgh, II , Tamara S. Vetro Widenhouse , Mark S. Zeiner , Andrew M. Zwolinski
- 主分类号： A61M37/00
- IPC分类号： A61M37/00 ; A61P3/00 ; A61K9/00 ; A61F2/04 ; A61K49/00 ; A61P3/04 ; A61B10/02 ; A61M5/00 ; A61K35/55 ; A61K9/20
摘要：
L-cells may be introduced in the gastrointestinal tract. L-cells are used in the digestive process to produce a more efficient and lasting means of regulating feelings of satiation in a patient. Desired metabolic effects may be achieved by manipulating L-cells via delivery sites, frequency of delivery, or type of biological substance delivered.
信息查询
IPC分类:
